Cargando…

HIV cure trial mergers: Spotlighting the epigenetics of latency reversal

Detalles Bibliográficos
Autor principal:	Denton, Paul W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048128/ https://www.ncbi.nlm.nih.gov/pubmed/35453079 http://dx.doi.org/10.1016/j.ebiom.2022.104012

Ejemplares similares

The merger that made us
por: Baum, Buzz, et al.
Publicado: (2020)

The role of latency reversal in HIV cure strategies
por: Tanaka, Kiho, et al.
Publicado: (2022)

Out of the shadows, into the spotlight: Invisible zoonotic diseases in Brazil
por: de Oliveira, Renata Carvalho, et al.
Publicado: (2022)

A spotlight on heightened T cell complexity and relevance in mucosal tissues
por: Lund, Jennifer M.
Publicado: (2022)

Rise in cholera amid COVID-19: Spotlight on Pakistan and Bangladesh
por: Ahmed, Syed Hassan, et al.
Publicado: (2022)

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
por: Søgaard, Ole S., et al.
Publicado: (2015)

Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
por: Clutton, Genevieve Tyndale, et al.
Publicado: (2018)

New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
por: Bricker, Katherine M., et al.
Publicado: (2021)

Control of HIV Latency by Epigenetic and Non-Epigenetic Mechanisms
por: Mbonye, Uri, et al.
Publicado: (2011)

HIV-1 Latency and Latency Reversal: Does Subtype Matter?
por: Sarabia, Indra, et al.
Publicado: (2019)

Epigenetic Regulation of HIV-1 Sense and Antisense Transcription in Response to Latency-Reversing Agents
por: Li, Rui, et al.
Publicado: (2023)

HIV Latency in Myeloid Cells: Challenges for a Cure
por: Chitrakar, Alisha, et al.
Publicado: (2022)

Epigenetic Heterogeneity in HIV-1 Latency Establishment
por: Matsuda, Yuka, et al.
Publicado: (2015)

Community engagement group model in basic and biomedical research: lessons learned from the BEAT-HIV Delaney Collaboratory towards an HIV-1 cure
por: Dubé, Karine, et al.
Publicado: (2023)

The role of miR-29a in HIV-1 replication and latency
por: Frattari, Giacomo, et al.
Publicado: (2017)

Communicating science: epigenetics in the spotlight
por: Dyke, Stephanie O M, et al.
Publicado: (2020)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
por: Lewis, Catherine A., et al.
Publicado: (2023)

If there is not one cure for schizophrenia, there may be many
por: Seah, Carina, et al.
Publicado: (2020)

Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
por: Kauder, Steven E., et al.
Publicado: (2009)

Merger Arbitrage
por: Kirchner, Thomas
Publicado: (2016)

Ambivalence in genomic healthcare provision, cure or symptom?
por: Watts, Gabriel
Publicado: (2023)

Diverse effects of interferon alpha on the establishment and reversal of HIV latency
por: Van der Sluis, Renée M., et al.
Publicado: (2020)

Deep latency: A new insight into a functional HIV cure
por: Elsheikh, Maher M., et al.
Publicado: (2019)

Tracking HIV Rebound following Latency Reversal Using Barcoded HIV
por: Marsden, Matthew D., et al.
Publicado: (2020)

Epigenetics of neural differentiation: Spotlight on enhancers
por: Giacoman-Lozano, Mayela, et al.
Publicado: (2022)

Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5–8 Days
por: Pinkevych, Mykola, et al.
Publicado: (2016)

TADsplimer reveals splits and mergers of topologically associating domains for epigenetic regulation of transcription
por: Wang, Guangyu, et al.
Publicado: (2020)

Impacts of HIV Cure Interventions on Viral Reservoirs in Tissues
por: Denton, Paul W., et al.
Publicado: (2019)

Combinatorial Use of Both Epigenetic and Non-Epigenetic Mechanisms to Efficiently Reactivate HIV Latency
por: Hokello, Joseph, et al.
Publicado: (2021)

Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies
por: Delannoy, Aurélie, et al.
Publicado: (2019)

Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure
por: Ventura, John D.
Publicado: (2020)

Valuation for Mergers and Acquisitions
por: Ferris, Kenneth
Publicado: (2013)

Making Mergers Work
por: Kimberly, John
Publicado: (2012)

Mergers & Acquisitions For Dummies
por: Snow, Bill
Publicado: (2018)

Mergers and Acquisitions Basics
por: DePamphilis, Donald
Publicado: (2010)

Help cure Parkinson’s disease: please don’t waste the Golden Year
por: Hauser, Robert A.
Publicado: (2018)

Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection
por: Saleh, Suha, et al.
Publicado: (2017)

Merger mania: mergers and acquisitions in the generic drug sector from 1995 to 2016
por: Gagnon, Marc-André, et al.
Publicado: (2017)

Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran
por: Giannandrea, David, et al.
Publicado: (2019)

CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies
por: Gray, L R, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_atvhnqvf0h2lnkfh22hftvbe87